Beyeler, Morin http://orcid.org/0000-0001-5911-7957
Pohle, Fabienne
Weber, Loris
Mueller, Madlaine
Kurmann, Christoph C.
Mujanovic, Adnan
Clénin, Leander
Piechowiak, Eike Immo
Meinel, Thomas Raphael
Bücke, Philipp
Jung, Simon
Seiffge, David
Pilgram-Pastor, Sara M.
Dobrocky, Tomas
Arnold, Marcel
Gralla, Jan
Fischer, Urs
Mordasini, Pasquale
Kaesmacher, Johannes
Funding for this research was provided by:
University of Bern
Article History
Received: 5 March 2023
Accepted: 13 July 2023
First Online: 29 August 2023
Declarations
:
: J. Kaesmacher reports grants from the Swiss Academy of Medical Sciences/Bangerter Foundation, Swiss Stroke Society, and Clinical Trials Unit Bern during the conduct of the study. U. Fischer reports grants during the conduct of the study from Medtronic, Stryker, and CSL Behring, unrelated to the submitted work. J. Gralla is a global principal investigator of STAR (Solitaire FR Thrombectomy for Acute Revascularisation), Clinical Event Committee member of the PROMISE study (Prospective, Multicenter, Observational, Single-Arm European Registry on the ACE Reperfusion Catheters and the Penumbra System in the Treatment of Acute Ischemic Stroke; Penumbra), and a principal investigator and consultant for the SWIFT DIRECT study (Solitaire With the Intention for Thrombectomy Plus Intravenous tPA Versus DIRECT Solitaire Stent-Retriever Thrombectomy in Acute Anterior Circulation Stroke; Medtronic) and receives Swiss National Science Foundation grants for magnetic resonance imaging in stroke. M. Arnold reports personal fees from Bayer, Bristol-Myers Squibb, Medtronic, Amgen, Daiichi Sankyo, Nestlé Health Sciences, Boehringer Ingelheim, and Covidien during the conduct of the study. T.R. Meinel reports research support from the Bangerter Rhyner Foundation, Swiss National Foundation, and the Swiss Heart Foundation. P. Mordasini reports receipt of research support from Siemens, Cerenovus, iSchmaview, Medtronic, Stryker, the Swiss Heart Foundation and the Swiss National Foundation, and receipt of consultant fees from Medtronic, Cerenovus, Phenox and Microvention during the conduct of the study, unrelated to the submitted work. E.I. Piechowiak reports grants from the Swiss National Science Foundation. M. Beyeler, F. Pohle, L. Weber, M. Mueller,C.C. Kurmann, A. Mujanovic, L. Clénin, P. Bücke, S. Jung, D. Seiffge, S.M. Pilgram-Pastor and T. Dobrocky declare that they have no competing interests.
: All procedures performed in studies involving human participants or on human tissue were in accordance with the Swiss law (reference ID: 2019-00547, Kantonale Ethikkomission Bern) and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.